Although increased adiponectin levels in sarcopenia are still being studied [4,5,8,10,16], some possible mechanisms have been proposed to explain the peculiarity: down-regulation of adiponectin receptor signaling [8,32], deposition of adipose tissue in muscles that may influence adiponectin expression [8,34], and activation of catabolism related to the presence of other comorbidities [8,33]. Here, ADIPOQ is linked to sarcopenia.